Jun 1, 2021

ST PHARM, the first company developing mRNA-LNP vaccine in South Korea

  • ST PHARM will the development of its own COVID-19 mRNA vaccine
  • It will apply  Genevant's LNP and ST PHARM's patented capping technology (SMARTCAP)
  • ST PHARM, the only company in the world that can produce 5'-capping and LNP